Table 2.
Clinical characteristics of participants of Diabetes Autoimmunity Study in the Young (DAISY) Study
| Characteristic | Control, N = 30 | Progressor, N = 47 | Non-progressor, N = 35 | p valueb |
|---|---|---|---|---|
| Sex, n (%) | 0.8 | |||
| Female | 17 (57%) | 24 (51%) | 17 (49%) | |
| Male | 13 (43%) | 23 (49%) | 18 (51%) | |
| FDR, n (%) | 0.5 | |||
| No | 15 (50%) | 17 (36%) | 15 (43%) | |
| Yes | 15 (50%) | 30 (64%) | 20 (57%) | |
| Draw Agea | 8.0 (5.4, 11.1) | 6.6 (4.1, 8.5) | 8.9 (4.1, 10.6) | 0.1 |
| HLA risk | 0.4 | |||
| H | 18 (60%) | 35 (74%) | 25 (71%) | |
| L | 12 (40%) | 12 (26%) | 10 (29%) |
All p values were two-sided and a p < 0.05 was considered significant.
aMedian (IQR).
bPearson’s Chi-squared test; Kruskal–Wallis rank sum test.